FI940424A7 - Heksahydronaftaleenin esterijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt - Google Patents

Heksahydronaftaleenin esterijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt Download PDF

Info

Publication number
FI940424A7
FI940424A7 FI940424A FI940424A FI940424A7 FI 940424 A7 FI940424 A7 FI 940424A7 FI 940424 A FI940424 A FI 940424A FI 940424 A FI940424 A FI 940424A FI 940424 A7 FI940424 A7 FI 940424A7
Authority
FI
Finland
Prior art keywords
preparation
ester derivatives
therapeutic uses
hexahydronaphthalene
hexahydronaphthalene ester
Prior art date
Application number
FI940424A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940424A0 (fi
Inventor
Sadao Ishihara
Hiroshi Kogen
Teiichiro Koga
Eiichi Kitazawa
Nobufusa Serizawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI940424A0 publication Critical patent/FI940424A0/fi
Publication of FI940424A7 publication Critical patent/FI940424A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • C07C69/736Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
FI940424A 1993-01-29 1994-01-28 Heksahydronaftaleenin esterijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt FI940424A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1306393 1993-01-29

Publications (2)

Publication Number Publication Date
FI940424A0 FI940424A0 (fi) 1994-01-28
FI940424A7 true FI940424A7 (fi) 1994-11-07

Family

ID=11822687

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940424A FI940424A7 (fi) 1993-01-29 1994-01-28 Heksahydronaftaleenin esterijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt

Country Status (21)

Country Link
US (1) US5491167A (cs)
EP (1) EP0609058B1 (cs)
JP (1) JPH06279280A (cs)
KR (1) KR100293335B1 (cs)
CN (1) CN1070487C (cs)
AT (1) ATE174324T1 (cs)
AU (1) AU664323B2 (cs)
CA (1) CA2114450A1 (cs)
CZ (1) CZ285658B6 (cs)
DE (1) DE69415050T2 (cs)
DK (1) DK0609058T3 (cs)
ES (1) ES2126057T3 (cs)
FI (1) FI940424A7 (cs)
HU (1) HU221852B1 (cs)
IL (1) IL108432A (cs)
NO (1) NO300769B1 (cs)
NZ (1) NZ250771A (cs)
PH (1) PH31662A (cs)
RU (1) RU2114101C1 (cs)
TW (1) TW411337B (cs)
ZA (1) ZA94548B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
US5942423A (en) * 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
MY127609A (en) * 2000-08-07 2006-12-29 Novartis Ag Process for preparing discodermolide and analogues thereof
DK1317419T3 (da) * 2000-09-06 2009-06-15 Emisphere Tech Inc Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
JP3236282B1 (ja) * 2000-10-16 2001-12-10 三共株式会社 プラバスタチンを精製する方法
RU2217141C1 (ru) * 2002-11-20 2003-11-27 Балавадзе Михаил Элизбарович Состав "витализин-1" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний
CL2008001205A1 (es) 2007-04-27 2008-11-14 Actelion Pharmaceuticals Ltd Compuestos derivados de biciclo[2.2.2]octeno; composicion farmaceutica que los contiene; y uso en el tratamiento o prevencion de angina cronica estable, hipertension, isquemia renal y cardiaca, arritmias cardiacas, hipertrofia cardiaca y falla congestiva del corazon.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS57185275A (en) * 1981-05-07 1982-11-15 Sankyo Co Ltd Tetrahydro-dum-4 and tetrahydro-isodum-4 and their derivatives
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd 3−ヒドロキシ−ml−236b誘導体の製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4937263A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4937264A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4902709A (en) * 1987-03-17 1990-02-20 Merck & Co., Inc. Novel antihypercholesterolemic compounds
US4885314A (en) * 1987-06-29 1989-12-05 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US4946864A (en) * 1988-02-01 1990-08-07 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US5021453A (en) * 1988-03-02 1991-06-04 Merck & Co., Inc. 3-keto HMG-CoA reductase inhibitors
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US4963538A (en) * 1988-06-29 1990-10-16 Merck & Co., Inc. 5-oxygenated HMG-CoA reductase inhibitors
US5130306A (en) * 1989-03-13 1992-07-14 Merck & Co., Inc. 5-Oxygenated HMG-COA reductase inhibitors
US5010105A (en) * 1989-06-09 1991-04-23 Merck & Co., Inc. Antihypercholesterolemic compounds
US5102911A (en) * 1989-06-09 1992-04-07 Merck & Co, Inc. 4-Substituted HMG-CoA reductase inhibitors
DE69008277D1 (de) * 1989-08-31 1994-05-26 Merck & Co Inc 7-Subsituierte HMG-CoA-Reduktase-Inhibitoren.

Also Published As

Publication number Publication date
AU5472894A (en) 1994-08-04
CA2114450A1 (en) 1994-07-30
KR940018352A (ko) 1994-08-16
ATE174324T1 (de) 1998-12-15
PH31662A (en) 1999-01-12
IL108432A (en) 1997-09-30
NO940309L (no) 1994-08-01
CN1098099A (zh) 1995-02-01
TW411337B (en) 2000-11-11
IL108432A0 (en) 1994-04-12
EP0609058A2 (en) 1994-08-03
DK0609058T3 (da) 1999-08-16
HUT67740A (en) 1995-04-28
DE69415050T2 (de) 1999-08-12
CZ285658B6 (cs) 1999-10-13
DE69415050D1 (de) 1999-01-21
NZ250771A (en) 1995-07-26
FI940424A0 (fi) 1994-01-28
RU2114101C1 (ru) 1998-06-27
CN1070487C (zh) 2001-09-05
US5491167A (en) 1996-02-13
ES2126057T3 (es) 1999-03-16
NO940309D0 (no) 1994-01-28
ZA94548B (en) 1994-08-29
NO300769B1 (no) 1997-07-21
KR100293335B1 (ko) 2001-09-17
JPH06279280A (ja) 1994-10-04
EP0609058A3 (en) 1995-04-19
AU664323B2 (en) 1995-11-09
HK1011678A1 (en) 1999-07-16
HU221852B1 (hu) 2003-02-28
HU9400242D0 (en) 1994-05-30
CZ18694A3 (en) 1995-03-15
EP0609058B1 (en) 1998-12-09

Similar Documents

Publication Publication Date Title
FI935895A7 (fi) Heksahydronaftaleeniesterin johdannaiset, niiden valmistus ja niiden terapeuttiset käytöt
FI20000516A7 (fi) Bis-indolyylimaleimidijohdannaiset ja niiden valmistus
FI955248A7 (fi) 1-Bifenyylimetyyli-imitdatsolin johdannaiset, niiden valmistus ja terapeuttinen käyttö
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
FI961599A7 (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
FI941137L (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI935074A7 (fi) Uusia tiopyranopyrrolijohdannaisia ja niiden valmistus
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
FI953479A7 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI940904A7 (fi) Oksatsolidiinidionijohdannaiset, niiden valmistus ja käyttö
FI935897L (fi) Pyridopyrimidiinijohdannaiset, niiden valmistus ja käyttö
FI943912L (fi) Tienopyrimidiinijohdannaiset, niiden valmistus ja käyttö
FI921459A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI914611A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FI965193A0 (fi) Triterpeenijohdannainen ja lääkeseos
FI941068A7 (fi) Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI922982A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja niiden terapeuttinen käyttö
FI940424A7 (fi) Heksahydronaftaleenin esterijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt
FI942294A7 (fi) Bentsopyraanijohdannaiset ja niiden käyttö
FI934221A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI955679A7 (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
FI944040A7 (fi) Laktolijohdannaiset, niiden valmistus ja käyttö
FI925833A7 (fi) Trisyklinen triatsolijohdannainen, sen valmistus ja sen käyttö
FI941958A7 (fi) 2-heterosyklinenetyyliamiinijohdannaiset ja niiden käyttö lääkkeinä